Logo

Novacyt Molecular HPV Testing Service

Jun 24, 2015

Novacyt has launched a molecular human papillomavirus service for all of its customers currently using its next-generation NOVAprep liquid-based cytology platform for cervical cancer screening.

Novacyt will offer the new service out of its Cambridge, UK labs using Abbott's RealTime High-Risk HPV PCR assay, and customers will be able to use the same NOVAprep consumable vial and medium for both Novacyt's cytology platform and Abbott's assay. Novacyt has validated the use of the Abbott PCR assay with the NOVAprep cytology medium in cervical cancer screening for additional HPV reflex testing. HPV testing provides important information about whether a patient has an HPV infection with any of the 14 high-risk HPV types, and this information, along with the result of the Pap smear, can be useful in managing patients with inconclusive results, the company noted.

Breaking News
The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.